The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells

被引:10
作者
Page, TJ
Mata, JE
Bridge, JA
Siebler, JC
Neff, JR
Iversen, PL
机构
[1] AVI BioPharma, Corvallis, OR 97333 USA
[2] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
[3] Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA
[4] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[5] Univ Nebraska, Med Ctr, Dept Orthopaed Surg, Omaha, NE 68198 USA
关键词
phosphorothioate oligonucleotide; telomere; telomerase inhibitor; lymphoma; sarcoma; drug development;
D O I
10.1006/excr.1999.4613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomerase is a ribonucleoprotein that adds 5'-d(T-TAGGG)-3' hexameric repeats onto the 3' ends of chromosomes. High telomerase activity has been associated with immortal cells, transformed cells, mitogenic stimulation, and proliferative diseases. It is not clear what phenotype would be observed by transient inhibition of telomerase. Studies were designed to inhibit telomerase activity using a series of S-ODN telomere sequence motifs. The studies evaluated the length, hydrogen bonding, and sequence requirements of telomerase inhibition using the TRAP assay and a bioassay measuring cell viability following exposure to the compounds. In addition, we have also studied the role of the 3' end and secondary structure of telomere mimics on telomerase inhibition. Observations reveal that sensitivity to the S-ODNs may not require hybridization to an antisense target but required guanine nucleotides on the 3' end for cells in culture and telomerase inhibition in vitro. The importance of H bonding and the requirement for a free 3' end for the activity of these compounds has also been demonstrated. However, transient inhibition of telomerase is not cytotoxic to all immortal cells and is not sufficient to explain the mechanism of cytotoxicity of these short oligonucleotides. (C) 1999 Academic Press.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 44 条
[1]  
Baeuerle PA, 1996, PATHOL BIOL, V44, P29
[3]   Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis [J].
Blasco, MA ;
Rizen, M ;
Greider, CW ;
Hanahan, D .
NATURE GENETICS, 1996, 12 (02) :200-204
[4]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[5]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[6]   REACTION OF GLYOXAL WITH NUCLEIC ACID COMPONENTS .3. KINETICS OF REACTION WITH MONOMERS [J].
BROUDE, NE ;
BUDOWSKY, EI .
BIOCHIMICA ET BIOPHYSICA ACTA, 1971, 254 (03) :380-&
[7]   Inhibition of telomerase activity by cisplatin in human testicular cancer cells [J].
Burger, AM ;
Double, JA ;
Newell, DR .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) :638-644
[8]   THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM [J].
BURGESS, TL ;
FISHER, EF ;
ROSS, SL ;
BREADY, JV ;
QIAN, YX ;
BAYEWITCH, LA ;
COHEN, AM ;
HERRERA, CJ ;
HU, SSF ;
KRAMER, TB ;
LOTT, FD ;
MARTIN, FH ;
PIERCE, GF ;
SIMONET, L ;
FARRELL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4051-4055
[9]   Oxidative damage to DNA: Do we have a reliable biomarker? [J].
Collins, AR ;
Dusinska, M ;
Gedik, CM ;
Stetina, R .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 :465-469
[10]   TELOMERASE ACTIVITY IN HUMAN OVARIAN-CARCINOMA [J].
COUNTER, CM ;
HIRTE, HW ;
BACCHETTI, S ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :2900-2904